As the most common infection among sick patients in intensive care units, OHSU will begin its clinical trial to test if a specialized breathing tube can reduce the risk of pneumonia in emergency intubation situations.
By acquiring OHSU's MolecularMD, the clinical research organization ICON, based in Dublin, Ireland, has expanded its laboratory offering in molecular diagnostic testing and brings expanded testing platforms.
This email was sent to you by Oregon Health & Science University
3181 S.W. Sam Jackson Park Rd. | Portland, Oregon 97239-3098